Compare GNLX & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNLX | L |
|---|---|---|
| Founded | 2001 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 22.0B |
| IPO Year | 2023 | N/A |
| Metric | GNLX | L |
|---|---|---|
| Price | $3.39 | $105.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | 135.3K | ★ 812.0K |
| Earning Date | 11-05-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.86 |
| Revenue | N/A | ★ $18,266,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.34 |
| Revenue Growth | N/A | ★ 6.06 |
| 52 Week Low | $1.99 | $78.98 |
| 52 Week High | $8.54 | $109.06 |
| Indicator | GNLX | L |
|---|---|---|
| Relative Strength Index (RSI) | 28.76 | 50.30 |
| Support Level | $3.32 | $103.26 |
| Resistance Level | $4.99 | $106.16 |
| Average True Range (ATR) | 0.34 | 1.30 |
| MACD | -0.05 | -0.22 |
| Stochastic Oscillator | 6.59 | 40.16 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.